Skip to main content
Log in

Studies on the activity of the renin-angiotensin-aldosterone system (RAAS) in patients with cirrhosis of the liver

Untersuchungen zur Aktivität des Renin-Angiotensin-Aldosteron Systems (RAAS) bei Patienten mit Lebercirrhose

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Zusammenfassung

Im Plasma von 77 Patienten mit Lebercirrhose [Gruppe I: unbehandelte Kranke mit Aszites (n=23); Gruppe II: dekompensierte Patienten während saluretischer Behandlung (n=32); Gruppe III: nach Aszitesausschwemmung, aber unter weiterer Spironolacton-Therapie (n=10); Gruppe IV: kompensierte, unbehandelte Cirrhosen (n=12)] wurden radioimmunologisch Reninaktivität (PRA) und Reninkonzentration (PRC), Angiotensinogen, Angiotensin II (AT II) und Aldosteron bestimmt. Abgesehen von einer Angiotensinogen-Verminderung zwischen 39% (Gruppe IV) und 73% (Gruppe III) in allen Gruppen waren bei unbehandelten Patienten in der Regel keine Veränderungen der übrigen Parameter des RAAS nachweisbar. Bei behandelten Kranken mit (Gruppe II) oder ohne (Gruppe III) Aszites fand sich eine hochsignifikante Zunahme der PRA, PRC, AT II- und Aldosteron-Plasmaspiegel. In der gesamten Cirrhosegruppe ergab sich eine enge, direkt proportionale Beziehung zwischen AT II und PRA, PRC sowie Aldosteron, was auf eine vorrangige Bedeutung von AT II für die Stimulierung der Aldosteronsekretion hindeutet. Die Plasma-Natriumkonzentration war invers zur PRA, PRC und zum AT II wie zum Aldosteron korreliert, jedoch konnte keine Beziehung zum Plasmakalium festgestellt werden.

Aus den erhobenen Befunden geht hervor, daß ein Hyperaldosteronismus bei Cirrhosekranken kaum als Ursache für die übersteigerte renale Natriumretention und die Aszitesbildung in Frage kommt. Überwiegend wird die Stimulierung des RAAS erst durch therapeutische Eingriffe und/oder durch ausgeprägte Störungen des Elektrolyt-Stoffwechsels hervorgerufen. Daher sind genau definierte Ausgangsbedingungen für die Untersuchung von Cirrhosepatienten unerläßlich, um therapiebedingte Aktivitätssteigerungen des RAAS ausschließen zu können.

Summary

Plasma renin activity (PRA), plasma renin concentration (PRC), angiotensinogen, angiotensin II (AT II) and plasma aldosterone were determined by radioimmunoassay in 77 patients with cirrhosis of the liver [group I: with ascites, untreated (n=23); group II: patients with ascites during treatment (n=32); group III: after removal of fluids, but under further spironolactone therapy (n=10); group IV: untreated subjects without ascites (n=12)]. With the exception of decreased angiotensinogen values in all groups ranging between 39% (group IV) and 73% (group III) no significant changes of the other parameters of the RAAS were found in untreated patients. A highly significant increase of PRA, PRC, AT II and plasma aldosterone was observed in treated cirrhotics with (group II) or without (group III) ascites. In the total series of patients AT II was closely related to PRA, PRC and aldosterone emphasizing again the predominant role of AT II to stimulate aldosterone secretion. Plasma sodium was inversely correlated to PRA, PRC, AT II and aldosterone, but no relationship was detected between these parameters of the RAAS and plasma potassium.

Our results indicate that hyperaldosteronism in cirrhosis appears unlikely to be the major determinant of avid renal sodium retention and ascites formation. An increased activity of the RAAS is most often initiated by therapeutic factors and/or markedly altered electrolyte metabolism. Therefore, basal conditions of the patients to be studied must be well defined to exclude any artificially induced stimulation of the RAAS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Ayers, C.R.: Plasma renin activity and renin-substrate concentration in patients with liver disease. Circ. Res.20, 594–598 (1967)

    Google Scholar 

  2. Ayers, C.R., Davis, J.O., Lieberman, F., Carpenter, C.C.J., Berman, M.: The effects of chronic hepatic venous congestion on the metabolism of d,l-aldosterone and d-aldosterone. J. clin. Invest.41, 884–895 (1962)

    Google Scholar 

  3. Barnardo, D.E., Strong, C.G., Baldus, W.P.: Failure of the cirrhotic liver to inactivate renin: Evidence for a splanchnic source of renin-like activity. J. Lab. clin. Med.74, 496–506 (1969)

    Google Scholar 

  4. Barnardo, D.E., Summerskill, W.H.J., Strong, C.G., Baldus, W.P.: Renal function, renin activity and endogenous vasoactive substances in cirrhosis. Amer. J. Dig. Dis.15, 419–425 (1970)

    Google Scholar 

  5. Berkowitz, H.D., Galvin, C.C., Miller, L.D.: The control of renal cortical perfusion by the renin angiotensin system. Ann. Surg.179, 238–245 (1974)

    Google Scholar 

  6. Berkowitz, H.D., Miller, L.D., Rosato, E.F.: Renin substrate depletion in hepatorenal syndrome. New Engl. J. Med.290, 461 (1974)

    Google Scholar 

  7. Birkenfeld, L.W., Leibman, J., O'Meara, M.P., Edelman, I.S.: Total exchangeable sodium, total exchangeable potassium, and total body water in edematous patients with cirrhosis of the liver and congestive heart failure. J. clin. Invest.37, 687–698 (1958)

    Google Scholar 

  8. Blair-West, J.R., Coghlan, J.P., Denton, D.A., Funder, J.W., Scoggins, B.A., Wright, R.D.: The effect of the heptapeptide (2–8) and the hexapeptide (3–8) fragments of angiotensin II on aldosterone secretion. J. clin. Endocr.32, 575–578 (1971)

    Google Scholar 

  9. Brown, J.J., Davies, D.L., Johnson, V.W., Lever, A.F., Robertson, J.I.S.: Renin relationships in congestive cardiac failure, treated and untreated. Amer. Heart J.80, 329–342 (1970)

    Google Scholar 

  10. Brown, J.J., Davies, D.L., Lever, A.F., Robertson, J.I.S.: Variations in plasma renin concentration in several physiological and pathological states. Canad. med. Ass. J.90, 201–206 (1964)

    Google Scholar 

  11. Bull, M.B., Hillman, R.S., Cannon, P.J., Laragh, J.H.: The control of renin and aldosterone secretion: Influence of sodium and potassium balance and changes in blood volume. J. clin. Invest.45, 992–993 (1966)

    Google Scholar 

  12. Camargo, C.A., Dowdy, A.J., Hancock, E.W., Luetscher, J.A.: Decreased plasma clearance and hepatic extraction of aldosterone in patients with heart failure. J. clin. Invest.44, 356–365 (1965)

    Google Scholar 

  13. Casey, T.H., Summerskill, W.H.J., Orvis, A.L.: Body and serum potassium in liver disease. I. Relationship to hepatic function and associated factors. Gastroenterology48, 198–207 (1965)

    Google Scholar 

  14. Christlieb, A.R., Couch, N.P., Amsterdam, E.A., Dobrzynski, S.J., Hickler, R.B.: Renin extraction by the human liver. Proc. Soc. exp. Biol. Med.128, 821–823 (1968)

    Google Scholar 

  15. Conn, J.W.: Aldosterone in clinical medicine—past, present, and future. Arch. intern. Med.97, 135–144 (1956)

    Google Scholar 

  16. Coppage jr., W.S., Island, D.P., Cooner, A.E., Liddle, G.W.: The metabolism of aldosterone in normal subjects and in patients with hepatic cirrhosis. J. clin. Invest.41, 1672–1680 (1962)

    Google Scholar 

  17. Cottin, S., Miniconi, P., Belet, J.-L., Cadudal, J.-L., Talmant, J.C., Bailleux, A.: Evolution de l'activité rénine du plasma chez des cirrhotiques décompensés, sous divers traitements déplétifs. Thérapie28, 803–813 (1973)

    Google Scholar 

  18. Cox, J.R., Davies-Jones, G.A.B., Leonard, P.J.: Sodium content and urinary aldosterone excretion in patients with congestive heart failure before and after treatment and comparison with normal subjects undergoing salt restriction. Clin. Sci.26, 177–184 (1964)

    Google Scholar 

  19. Crane, M.G., Harris, J.J.: Desoxycorticosterone secretion rate studies in edematous patients. Amer. J. Med. Sci.259, 27–31 (1970)

    Google Scholar 

  20. Cunningham, J.M., jr., Carter, N.W., Rector jr., F.C., Seldin, D.W.: Resting transmembrane potential difference of skeletal muscle in normal subjects and severely ill patients. J. clin. Invest.50, 49–59 (1971)

    Google Scholar 

  21. Demanet, J.C., Bonnyns, M., Bleiberg, H., Stevens-Roomans, C.: Coma due to water intoxication in beer drinkers. LancetII, 1115–1117 (1971)

    Google Scholar 

  22. Dyrenfurth, I., Stacey, C.H., Beck, J.C., Venning, E.H.: Aldosterone excretion in patients with cirrhosis of the liver. Metabolism6, 544–555 (1957)

    Google Scholar 

  23. Earley, L.E., Daugharty, T.M.: Sodium metabolism. New Engl. J. Med.281, 72–86 (1969)

    Google Scholar 

  24. Epstein, M., Pins, D.S., Schneider, N., Levinson, R.: Determinants of deranged sodium and water homeostasis in decompensated cirrhosis. J. Lab. clin. Med.87, 822–839 (1976)

    Google Scholar 

  25. Flear, C.T.G., Singh, C.M.: Hyponatremia and sick cells. Brit. J. Anaesth.45, 976–994 (1973)

    Google Scholar 

  26. Funder, J.W., Blair-West, J.R., Coghlan, J.P., Denton, D.A., Scoggins, B.A., Wright, R.D.: Effect of plasma K+ on the secretion of aldosterone. Endocrinology85, 381–384 (1969)

    Google Scholar 

  27. Genest, J., de Champlain, J., Veyrat, R., Koiw, E., Boucher, R.: The activity of the renin-angiotensin-aldosterone system in hypertensive and hydropic diseases. In: Aktuelle Probleme der Nephrologie, pp. 152–177. Eds.: Wolff, H.P., Gross, F.: Springer, Berlin-Heidelberg-New York (1966)

    Google Scholar 

  28. Gould, A.B., Skeggs, L.T., Kahn, J.R.: Measurement of renin and substrate concentrations in human serum. Lab. Invest.15, 1802–1813 (1966)

    Google Scholar 

  29. Haas, E., Gould, A.B., Goldblatt, H.: Estimation of endogenous renin in human blood. LancetI, 657–659 (1968)

    Google Scholar 

  30. Heacox, R., Harvey, A.M., Vander, A.J.: Hepatic inactivation of renin. Circ. Res.21, 149–152 (1967)

    Google Scholar 

  31. Hilden, T., Svendsen, T.L.: Electrolyte disturbances in beer drinkers. LancetII, 245–246 (1975)

    Google Scholar 

  32. Himathongkam, T., Dluhy, R.G., Williams, G.H.: Potassiumaldosterone-renin interrelationship. J. clin. Endocr.41, 153–159 (1975)

    Google Scholar 

  33. Hosie, K.F., Brown, J.J., Harper, A.M., Lever, A.F., Macadam, R.F., MacGregor, J., Robertson, J.I.S.: The release of renin into the renal circulation of the anaesthetized dog. Clin. Sci.38, 157–174 (1970)

    Google Scholar 

  34. Hurter, R., Nabarro, J.D.N.: Aldosterone metabolism in liver disease. Acta endocr. (Kbh)33, 168–174 (1960)

    Google Scholar 

  35. Iwatsuki, S., Popovtzer, M.M., Corman, J.L., Ishikawa, M., Putham, C.W., Katz, F.H., Starzl, T.E.: Recovery from “hepatorenal syndrome” after orthotopic liver transplantation. New Engl. J. Med.289, 1155–1159 (1973)

    Google Scholar 

  36. Jahrmärker, H., v. Bubnoff, M., Riecker, G.: Über Hyponatriämie-Syndrome und ihre Analyse durch Elektrolytbestimmung in Erythrocyten. Klin. Wschr.39, 317–333 (1961)

    Google Scholar 

  37. Kaufmann, W., Steiner, B., Dürr, F., Meurer, K.A., Behn, C.: Induzierter Aldosteronismus bei hydropischer Herzinsuffizienz. Klin. Wschr.47, 16–25 (1969)

    Google Scholar 

  38. Kaufmann, W., Steiner, B., Meurer, K.A., Dürr, F.: Aldosteron bei cardialer und hepataler Hypervolämie. In: Die Niere im Kreislauf, pp. 45–54. Eds.: Klütsch, K., Wollheim, E., Holtmeier, H.J.: Stuttgart, Thieme (1971)

    Google Scholar 

  39. Khayyall, M., MacGregor, J., Brown, J.J., Lever, A.F., Robertson, J.I.S.: Increase of plasma renin-substrate concentration after infusion of angiotensin in the rat. Clin. Sci.44, 87–90 (1973)

    Google Scholar 

  40. Kokot, F., Kuska, J., Czekala, Z.: Hepatic inactivation of renin in man. Enzym. Biol. Clin.9, 317–319 (1968)

    Google Scholar 

  41. Kondo, K., Nakamura, R., Saito, I., Saruta, T., Matsuki, S.: Renin, angiotensin II and juxtaglomerular apparatus in liver cirrhosis. Jap. Circ. J.38, 913–921 (1974)

    Google Scholar 

  42. Krause, K.D., Rosskamp, E., Meurer, K.A., Kaufmann, W.: Zur Reagibilität des Renin-Angiotensin-Systems bei kardialer Hydropsie: Hinweise auf eine vom Gesamtnatriumbestand abhängige Regulation der Reninfreisetzung. Klin. Wschr.50, 311–326 (1972)

    Google Scholar 

  43. Laragh, J.H., Cannon, P.J., Ames, R.P.: Interaction between aldosterone secretion, sodium and potassium balance, and angiotensin activity in man: Studies in hypertension and cirrhosis. Canad. med. Ass. J.90, 248–256 (1964)

    Google Scholar 

  44. Lieberman, F.L., Reynolds, T.B.: Plasma volume in cirrhosis of the liver: Its relation to portal hypertension, ascites and renal failure. J. clin. Invest.46, 1297–1308 (1967)

    Google Scholar 

  45. Mann, M., Siegenthaler, W.: Aldosteronstoffwechsel und Leberkrankheiten. Klin. Wschr.42, 885–890 (1964)

    Google Scholar 

  46. Massani, Z.M., Finkielman, S., Worcel, M., Agrest, A., Paladini, A.C.: Angiotensin blood levels in hypertensive and nonhypertensive diseases. Clin. Sci.30, 473–483 (1966)

    Google Scholar 

  47. Mouw, D.R., Vander, A.J.: Evidence for brain Na receptors controlling renal Na excretion and plasma renin activity. Amer. J. Physiol.219, 822–832 (1970)

    Google Scholar 

  48. Müller, G.: Einfache Technik zur Ausschaltung hoher “Blank-Werte” bei der radioimmunologischen Aldosteron-Bestimmung nach dünnschichtchromatographischer Trennung. (Manuscript in preparation)

  49. Nasjletti, A., Masson, G.M.C.: Effects of corticosteroids on plasma angiotensinogen and renin activity. Amer. J. Physiol.217, 1396–1400 (1969)

    Google Scholar 

  50. Panitch, N.M., Cole, D., Samloff, I.M., Horton, R.: The effect of β-adrenergic blockade in cirrhotic ascites. Gastroenterology68, 985 (1975)

    Google Scholar 

  51. Peach, M.J., Chiu, A.T.: Stimulation and inhibition of aldosterone biosynthesis in vitro by angiotensin II and analogs. Circ. Res. 34/35, Suppl.I, 7–13 (1974)

    Google Scholar 

  52. Rosoff jr., L., Zia, P., Reynolds, T., Horton, R.: Studies of renin and aldosterone in cirrhotic patients with ascites. Gastroenterology69, 698–707 (1975)

    Google Scholar 

  53. Saruta, T., Cook, R., Kaplan, N.M.: Adrenocortical steroidogenesis: Studies on the mechanism of action of angiotensin and electrolytes. J. clin. Invest.51, 2239–2245 (1972)

    Google Scholar 

  54. Schrier, R.W., de Wardener, H.E.: Tubular reabsorption of sodium ion: Influence of factors other than aldosterone and glomerular filtration rate. New Engl. J. Med.285, 1231–1243, 1292–1303 (1971)

    Google Scholar 

  55. Schroeder, E.T., Eich, R.H., Smulyan, H., Gould, A.B., Gabuzda, G.J.: Plasma renin level in hepatic cirrhosis. Amer. J. Med.49, 186–191 (1970)

    Google Scholar 

  56. Shaldon, S., McLaren, J.R.: An 11-β-hydroxylase inhibitor in the treatment of resistant ascites. LancetII, 1330–1332 (1960)

    Google Scholar 

  57. Sherlock, S., Shaldon, S.: The aetiology and management of ascites in patients with hepatic cirrhosis. A review. Gut4, 95–105 (1963)

    Google Scholar 

  58. Soler, N.G., Jain, S., James, H., Paton, A.: Potassium status of patients with cirrhosis. Gut17, 152–157 (1976)

    Google Scholar 

  59. Spech, H.J.: Total immunoreactive angiotensin II, its heptaoctapeptide fraction, and its hexapeptide in patients with liver disease. Klin. Wschr. (in press)

  60. Sundsfjord, J.A.: Radioimmunoassay of angiotensin II in plasma. Acta endocr. (Kbh)64, 181–192 (1970)

    Google Scholar 

  61. Tateishi, H., Masson, G.M.C.: Role of the liver in the regulation of plasma angiotensinogen and renin levels. Proc. Soc. exp. Biol. Med.139, 304–309 (1972)

    Google Scholar 

  62. Vecsei, P., Düsterdieck, G., Jahnecke, J., Lommer, D., Wolff, H.P.: Secretion and turnover of aldosterone in various pathological states. Clin. Sci.36, 241–256 (1969)

    Google Scholar 

  63. Vecsei, P., Gless, K.-H.: Aldosteron-Radioimmunoassay. Grundlagen—Durchführung—Anwendung. Stuttgart, Enke (1975)

    Google Scholar 

  64. Weigand, K., Wernze, H., Falge, C.: Synthesis and secretion of albumin and angiotensinogen by isolated rat liver cells. Hoppe-Seyler's Z. physiol. Chem.355, 1266–1267 (1974)

    Google Scholar 

  65. Wernze, H.: Changes of plasma renin-substrate in physiological and pathophysiological states. In: D. K. Krause, W. Hummerich, K. Poulsen (Ed.) Radioimmunoassay-Renin-Angiotensin Stuttgart, Thiemea 1978 (in press)

  66. Wernze, H., Seki, A., Michel, H.: Veränderungen der Serum-Angiotensinogen-Konzentration bei akuter Hepatitis und Lebercirrhosen. Klin. Wschr.50, 53–55 (1972)

    Google Scholar 

  67. Wilkinson, S.P., Alam, A., Moodie, H., Williams, R.: Renal retention of sodium in cirrhosis and fulminant hepatic failure. Postgrad. med. J. 527–531 (1975)

  68. Wolff, H.P., Bette, L., Blaise, H., Düsterdieck, G., Jahnecke, J., Kobayashi, T., Krück, F., Lommer, D., Schieffer, H.: Role of aldosterone in edema formation. Ann. N.Y. Acad. Sci.139, 285–294 (1966)

    Google Scholar 

  69. Wolff, H.P., Koczorek, K.R., Buchborn, E.: Aldosterone and antidiuretic hormone (adiuretin) in liver disease. Acta endocr. (Kbh)27, 45–58 (1958)

    Google Scholar 

  70. Ziegler, M., Gross, F.: Effect of blood volume changes on renin-like activity in blood. Proc. Soc. exp. Biol. Med.116, 774–778 (1964)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wernze, H., Spech, H.J. & Müller, G. Studies on the activity of the renin-angiotensin-aldosterone system (RAAS) in patients with cirrhosis of the liver. Klin Wochenschr 56, 389–397 (1978). https://doi.org/10.1007/BF01477293

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01477293

Schlüsselwörter

Key words

Navigation